Recent Events & Catalysts
Caris Life Sciences, Inc. (CAI) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Caris Life Sciences: Guidance Raised, Valuation Still Attractive
SeekingAlpha · 4d ago
Evercore ISI Group Maintains Outperform on Caris Life Sciences, Raises Price Target to $26
Benzinga · 5d ago
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript
SeekingAlpha · 6d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 6d ago
Caris Life Sciences Raises FY2026 Sales Guidance from $1.000B-$1.020B to $1.030B-$1.040B vs $1.003B Est
Benzinga · 6d ago
CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates
Yahoo · 12d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-05 · 6d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-05 · 67d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.